SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma
Background and Objective. Serine hydroxymethyltransferase 2 (SHMT2) functions as a key enzyme in serine/glycine biosynthesis and one-carbon metabolism. Recent studies have shown that SHMT2 participated in tumor growth and progression in a variety of cancer types. The objective of the present study i...
Saved in:
Main Authors: | Shanglei Ning, Siquan Ma, Abdul Qahar Saleh, Lingyu Guo, Zixiao Zhao, Yuxin Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2018/4369253 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Parameters Predicting Survival Duration after Hepatectomy for Intrahepatic Cholangiocarcinoma
by: Bei-ge Jiang, et al.
Published: (2011-01-01) -
Design of studies on neoadjuvant therapy for intrahepatic cholangiocarcinoma
by: Yuan Cheng, et al.
Published: (2025-01-01) -
Intraoperative Conversion to ALPPS in a Case of Intrahepatic Cholangiocarcinoma
by: F. Oldhafer, et al.
Published: (2015-01-01) -
What Are the Precursor and Early Lesions of Peripheral Intrahepatic Cholangiocarcinoma?
by: Yasuni Nakanuma, et al.
Published: (2014-01-01) -
Intrahepatic Sarcomatous Cholangiocarcinoma: Case Report and Review of the Literature
by: Thana Boonsinsukh, et al.
Published: (2018-01-01)